Navigation Links
Pulmo BioTech Inc. Announces that Its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) Shows Early Indications of Being Able to Diagnose a Wide Range of Medical Conditions Affecting the Physical and/or Biological Integrity of the Pulmon
Date:11/11/2009

NEW YORK, Nov. 11 /PRNewswire-FirstCall/ -- Pulmo BioTech Inc. (OTC Bulletin Board: PLMO.OB; Frankfort Borse: PBO) has announced that early experimental results have indicated that its PulmoBind(TM) product candidate can be potentially used for the early detection and follow-up of many conditions that affect the physical and/or biological integrity of the Pulmonary Circulation. These early results, if confirmed by further experiments, would broaden the range of conditions that PulmoBind(TM) is able to diagnose.

"We are very pleased with these early results. To date, we have mainly concentrated on the use of PulmoBind(TM) as a diagnostic agent for Pulmonary Hypertension (PH) and Pulmonary Embolism (PE). While our work in these areas continues, early experimental results have indicated that PulmoBind(TM) could be used to diagnose a wide range of Pulmonary Vascular diseases associated with lung disorders, heart disease and connective tissue disease. For example, lung disorders associated with HIV, Cirrhosis and Shistosomiasis are all conditions that we believe could potentially be diagnosed using PulmoBind(TM). If our experimental results can be confirmed, then PulmoBind(TM) has great potential as a front-line test to either confirm or exclude disorders of the Pulmonary Circulation in patients who present with "shortness of breath". PulmoBind(TM) could also help in predicting outcomes in these patients and guiding their therapy." - Garry McCann, CEO Pulmo BioTech Inc.

About Pulmo BioTech Inc.

Pulmo BioTech Inc. specializes in the development and marketing of medical technology and research. Our proven strengths combine extensive commercial experience and academic credentials. The principal staff members are acknowledged experts in their specialized fields, and work with a broad range of investment institutions. Our mission is to utilize scientific imagination and drive, together with managerial and financial acumen, to b
'/>"/>

SOURCE Pulmo BioTech Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension
2. Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday, November 1, 2007
3. Study Shows Need to Test More COPD and Asthma Patients for Underdiagnosed Pulmonary Disease
4. Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis
5. Edwards Lifesciences Announces First Implants in U.S. Study of Minimally-Invasive Pulmonic Valve
6. PulmoBioTech Announces Details of Its Regulatory Approval Experiments
7. Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension
8. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
9. Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
10. Positive Mid-Term Results on CryoValve(R) SG Pulmonary Human Heart Valve Presented at Western Thoracic Meeting
11. Pulmo BioTech Inc. Completes Bio-Distribution Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  TeamHealth Medical ... nurse triage and nurse advice lines, announces its ... comprising physician, nursing and administrative leaders, provides clinical ... quality and cost-effective services for hospital clients, physician ... national healthcare system evolves, it,s imperative to continuously ...
(Date:5/23/2013)... More than half of women diagnosed with ... and still have excellent outcomes. To educate women, Agendia, ... largest sources of online consumer information about breast cancer ... provide recently diagnosed women with information sources, to help ... "We anticipate these innovative social media campaigns will ...
(Date:5/23/2013)... 23, 2013 Anthem Blue Cross patients with ... required them to obtain their medications by mail order ... Whatley Kallas LLC.  The lawsuit, filed ... Blue Cross,s mandatory mail order program announced late last ... privacy. "This settlement brings to a close ...
Breaking Medicine Technology:TeamHealth Medical Call Center Forms Clinical Advisory Committee 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3
... results suggest the true prevalence of dementia may ... the world,s least developed regions - LONDON and ... 24th Conference of Alzheimer,s Disease International (ADI) address ... Alzheimer,s and dementia, as well as new ways ...
... in Health Care Decisions?CHARLOTTE, N.C., March 24 For ... healthy life at any age, or to turn around ... may have the answers right in your own backyard.The ... health and wellness event in the queen city. With ...
Cached Medicine Technology:Worldwide Cost Estimate for Alzheimer's and Dementia Is US$315.4 Billion 2Worldwide Cost Estimate for Alzheimer's and Dementia Is US$315.4 Billion 3Worldwide Cost Estimate for Alzheimer's and Dementia Is US$315.4 Billion 4Worldwide Cost Estimate for Alzheimer's and Dementia Is US$315.4 Billion 5Worldwide Cost Estimate for Alzheimer's and Dementia Is US$315.4 Billion 6Anti-Aging Expo & Symposium Showcases in Charlotte on March 28th 2
(Date:5/25/2013)... IBISWorld estimates that revenue for the Cell Therapy ... 28.7% to $1.0 billion in the five years to 2013, ... no new cell therapy products were introduced, according to IBISWorld ... period. In the years since, however, the Food and Drug ... to the industry's fast growth during the five years to ...
(Date:5/25/2013)... For college students, few events can ... are turning to prescription stimulants like Adderall to ... on this, go to http://www.sciencedaily.com/releases/2013/05/130501145151.htm . , ... students who pick up Adderall, “just to help ... a physical and psychological dependency. While initially they ...
(Date:5/25/2013)... 25, 2013 Ayurveda is the ... "knowledge or wisdom of life". While a medical science, its ... transformation of consciousness. Its fundamental philosophy is that disease is ... environment. It believes that in order to re-establish optimal health, ... and then adopt a life style which brings us back ...
(Date:5/25/2013)... The current residents of Back2Basics - Long Term Drug ... all came together Saturday, May 18th to celebrate the company's ... the residents got up to thank Roy Duprez, CEO and ... to recovery, and giving them a second chance at life. ... after realizing the need for a long-term facility. What ...
(Date:5/25/2013)... May 25, 2013 http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html ... a judge's overturning of a jury's award of $6.5 ... first trial* in the country over allegations that the ... court files. , The judge in the case ruled ... show his cancer was caused by the medication.** , ...
Breaking Medicine News(10 mins):Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2Health News:Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes 2Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 2Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 3Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 4
... Women who exercise by doing household chores like dusting, ... cancer, suggests a new study.// ,The research ... from nine European countries and found that doing housework ... the online edition of BBC News. , ,It ...
... 2002 Gay Pride, San Francisco Department of Public Health launched ... ,In the above said campaign, a cartoon penis by name ... of homo whores who had gathered there to get themselves ... not happy with the Ad and scoffed at the cartoon ...
... Medical Association (IMA) will oppose the government's plan to ... IMA will oppose the move to administer injections instead ... president Sanjeev Malik told IANS here. ,Malik ... that began Wednesday and to hand over charge to ...
... now strawberry wine will add variety from Himachal Pradesh.// ... Marketing Corp's (HPMC) juice and wine processing plant in Mandi ... was produced after year-long research by experts and will be ... Kinnaur district, which produces some of the best wines in ...
... disorder, characterized by inflammation of synovial tissue leading //to ... joints. Investigations made on laboratory rats prove that women ... ,Researchers at the Mayo Clinic have produced a new ... human RA patients and increased incidence of the disease ...
... you know that a flabby waist certainly points to a greater ... ,A recent study has revealed that the risk for coronary illness ... figure one sports a podgy flabby waistline. ,The diameter along the ... This roughly amounts to an imaginary line cutting through the body ...
Cached Medicine News:Health News:Rheumatoid Arthritis and Sex Bias 2
Frequency 55 Toric XR is a great option for those with high levels of astigmatism...
... SofLens66 Toric lens are fit ... current soft toric lens wearers who ... with the health and convenience of ... want the convenience of contact lenses; ...
The Heine C series binocular loupes offer extremely low weight (46g), crisp views, and quality German construction in an affordable instrument....
C 2.3K with lightweight headband: the practical alternative for spectacle-wearers. Delivered in protective designer case....
Medicine Products: